Your browser doesn't support javascript.
loading
Urinary adiponectin is an independent predictor of progression to end-stage renal disease in patients with type 1 diabetes and diabetic nephropathy.
Panduru, Nicolae M; Saraheimo, Markku; Forsblom, Carol; Thorn, Lena M; Gordin, Daniel; Wadén, Johan; Tolonen, Nina; Bierhaus, Angelika; Humpert, Per M; Groop, Per-Henrik.
Afiliação
  • Panduru NM; 2nd Clinical Department, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland Diabetes and Obesity Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland.
  • Saraheimo M; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland Diabetes and Obesity Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.
  • Forsblom C; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland Diabetes and Obesity Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.
  • Thorn LM; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland Diabetes and Obesity Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.
  • Gordin D; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland Diabetes and Obesity Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.
  • Wadén J; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland Diabetes and Obesity Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.
  • Tolonen N; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland Diabetes and Obesity Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.
  • Bierhaus A; Department of Medicine I and Clinical Chemistry, University of Heidelberg, Heidelberg, Germany.
  • Humpert PM; Stoffwechselzentrum Rhein Pfalz, Mannheim, Germany.
  • Groop PH; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland Diabetes and Obesity Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland Baker IDI H
Diabetes Care ; 38(5): 883-90, 2015 May.
Article em En | MEDLINE | ID: mdl-25720601
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Nefropatias Diabéticas / Adiponectina / Falência Renal Crônica Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Nefropatias Diabéticas / Adiponectina / Falência Renal Crônica Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article